1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. Nuclear Medicine Market, by Product
6.1. Introduction
6.2. Diagnostic Products
6.2.1. PET
6.2.1.1. F-18
6.2.1.2. SR-82/RB-82
6.2.2. SPECT
6.2.2.1. GA-67
6.2.2.2. I-123
6.2.2.3. TC-99m
6.2.2.4. TL-201
6.3. Therapeutic Products
6.3.1. Alpha Emitters
6.3.1.1. RA-223
6.3.2. Beta Emitters
6.3.2.1. I-131
6.3.2.2. Lu-117
6.3.2.3. Re-186
6.3.2.4. SM-153
6.3.2.5. Y-90
6.3.3. Brachytherapy
6.3.3.1. Cesium-131
6.3.3.2. Iodine-125
6.3.3.3. Iridium-192
6.3.3.4. Palladium-103

7. Nuclear Medicine Market, by Application
7.1. Introduction
7.2. Bone Metastasis
7.3. Cardiology
7.4. Endocrine Tumor
7.5. Lymphoma
7.6. Oncology
7.7. Thyroid

8. California Nuclear Medicine Market

9. Florida Nuclear Medicine Market

10. Illinois Nuclear Medicine Market

11. New York Nuclear Medicine Market

12. Ohio Nuclear Medicine Market

13. Pennsylvania Nuclear Medicine Market

14. Texas Nuclear Medicine Market

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles
16.1. Australian Nuclear Science & Technology Organization
16.2. Bayer AG
16.3. Bracco Imaging S.P.A.
16.4. BWX Technologies, Inc.
16.5. Cardinal Health, Inc.
16.6. Curium by CapVest Associates
16.7. Eckert & Ziegler Group
16.8. Eczacibasi-Monrol Nuclear Products
16.9. GE Healthcare
16.10. Global Medical Solutions, Ltd.
16.11. IBA Molecular
16.12. Institute of Isotopes Co., Ltd.
16.13. Isotopia Molecular Imaging Limited
16.14. Joint Stock Company Isotope
16.15. Jubilant Draximage, Inc.
16.16. Lantheus Medical Imaging, Inc.
16.17. Medtronic, Inc
16.18. Nordion, Inc
16.19. Northstar Medical Radioisotopes, LLC
16.20. Novartis AG
16.21. NTP Radioisotopes Soc, Ltd.
16.22. PharmaLogic Holdings Corp
16.23. Shine Medical Technologies
16.24. Sinotau Pharmaceuticals Group

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. UNITED STATES NUCLEAR MEDICINE MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2026
FIGURE 7. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 9. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2026 (USD MILLION)
FIGURE 10. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PET, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 11. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY F-18, 2018-2026 (USD MILLION)
FIGURE 12. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY F-18, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 13. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY SR-82/RB-82, 2018-2026 (USD MILLION)
FIGURE 14. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY SR-82/RB-82, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 15. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2026 (USD MILLION)
FIGURE 16. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 17. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY GA-67, 2018-2026 (USD MILLION)
FIGURE 18. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY GA-67, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 19. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY I-123, 2018-2026 (USD MILLION)
FIGURE 20. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY I-123, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 21. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY TC-99M, 2018-2026 (USD MILLION)
FIGURE 22. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY TC-99M, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 23. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY TL-201, 2018-2026 (USD MILLION)
FIGURE 24. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY TL-201, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 25. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2026 (USD MILLION)
FIGURE 26. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 27. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, 2018-2026 (USD MILLION)
FIGURE 28. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 29. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY RA-223, 2018-2026 (USD MILLION)
FIGURE 30. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY RA-223, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 31. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2026 (USD MILLION)
FIGURE 32. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 33. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY I-131, 2018-2026 (USD MILLION)
FIGURE 34. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY I-131, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 35. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY LU-117, 2018-2026 (USD MILLION)
FIGURE 36. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY LU-117, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 37. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY RE-186, 2018-2026 (USD MILLION)
FIGURE 38. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY RE-186, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 39. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY SM-153, 2018-2026 (USD MILLION)
FIGURE 40. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY SM-153, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 41. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY Y-90, 2018-2026 (USD MILLION)
FIGURE 42. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY Y-90, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 43. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2026 (USD MILLION)
FIGURE 44. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 45. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, 2018-2026 (USD MILLION)
FIGURE 46. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 47. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, 2018-2026 (USD MILLION)
FIGURE 48. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 49. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, 2018-2026 (USD MILLION)
FIGURE 50. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 51. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, 2018-2026 (USD MILLION)
FIGURE 52. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 53. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 54. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2026
FIGURE 56. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BONE METASTASIS, 2018-2026 (USD MILLION)
FIGURE 57. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BONE METASTASIS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 58. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2026 (USD MILLION)
FIGURE 59. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 60. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINE TUMOR, 2018-2026 (USD MILLION)
FIGURE 61. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINE TUMOR, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 62. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY LYMPHOMA, 2018-2026 (USD MILLION)
FIGURE 63. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY LYMPHOMA, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 64. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD MILLION)
FIGURE 65. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 66. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THYROID, 2018-2026 (USD MILLION)
FIGURE 67. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THYROID, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 68. UNITED STATES NUCLEAR MEDICINE MARKET: FPNV POSITIONING MATRIX
FIGURE 69. UNITED STATES NUCLEAR MEDICINE MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 70. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES NUCLEAR MEDICINE MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES NUCLEAR MEDICINE MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PET, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY F-18, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY SR-82/RB-82, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY GA-67, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY I-123, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY TC-99M, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY TL-201, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY RA-223, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY I-131, BY STATE, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY LU-117, BY STATE, 2018-2026 (USD MILLION)
TABLE 20. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY RE-186, BY STATE, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY SM-153, BY STATE, 2018-2026 (USD MILLION)
TABLE 22. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY Y-90, BY STATE, 2018-2026 (USD MILLION)
TABLE 23. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, BY STATE, 2018-2026 (USD MILLION)
TABLE 24. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY STATE, 2018-2026 (USD MILLION)
TABLE 25. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY STATE, 2018-2026 (USD MILLION)
TABLE 26. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY STATE, 2018-2026 (USD MILLION)
TABLE 27. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY STATE, 2018-2026 (USD MILLION)
TABLE 28. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 29. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BONE METASTASIS, BY STATE, 2018-2026 (USD MILLION)
TABLE 30. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 31. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINE TUMOR, BY STATE, 2018-2026 (USD MILLION)
TABLE 32. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY LYMPHOMA, BY STATE, 2018-2026 (USD MILLION)
TABLE 33. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 34. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THYROID, BY STATE, 2018-2026 (USD MILLION)
TABLE 35. UNITED STATES NUCLEAR MEDICINE MARKET: SCORES
TABLE 36. UNITED STATES NUCLEAR MEDICINE MARKET: BUSINESS STRATEGY
TABLE 37. UNITED STATES NUCLEAR MEDICINE MARKET: PRODUCT SATISFACTION
TABLE 38. UNITED STATES NUCLEAR MEDICINE MARKET: RANKING
TABLE 39. UNITED STATES NUCLEAR MEDICINE MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 40. UNITED STATES NUCLEAR MEDICINE MARKET: MERGER & ACQUISITION
TABLE 41. UNITED STATES NUCLEAR MEDICINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 42. UNITED STATES NUCLEAR MEDICINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 43. UNITED STATES NUCLEAR MEDICINE MARKET: INVESTMENT & FUNDING
TABLE 44. UNITED STATES NUCLEAR MEDICINE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 45. UNITED STATES NUCLEAR MEDICINE MARKET: LICENSE & PRICING

Companies Mentioned

Australian Nuclear Science & Technology Organization
Bayer AG
Bracco Imaging S.P.A.
BWX Technologies, Inc.
Cardinal Health, Inc.
Curium by CapVest Associates
Eckert & Ziegler Group
Eczacibasi-Monrol Nuclear Products
GE Healthcare
Global Medical Solutions, Ltd.
IBA Molecular
Institute of Isotopes Co., Ltd.
Isotopia Molecular Imaging Limited
Joint Stock Company Isotope
Jubilant Draximage, Inc.
Lantheus Medical Imaging, Inc.
Medtronic, Inc
Nordion, Inc
Northstar Medical Radioisotopes, LLC
Novartis AG
NTP Radioisotopes Soc, Ltd.
PharmaLogic Holdings Corp
Shine Medical Technologies
Sinotau Pharmaceuticals Group